On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization